Description
Patients are often not compliant with their therapy.
Pharmacists know how important it is for patients to take their
medication regularly; patients are healthier and the pharmacy has
better financial performance. The growth in e-prescribing and the
new Medicare prescription drug benefit are new developments that
can change the approach pharmacy staff take to increase patient
compliance. With e-prescribing, the pharmacist and the prescriber
can better track how regularly the patient is taking their medication.
And, with the Medicare prescription drug benefit, cost will be less
of an issue for patients who are currently unable to afford their
medicine. Find out how these new developments in Medicare can spike
your business and make patient compliance soar.
Learning
Objectives
Upon successful completion of this activity, the pharmacist should be better able
to:
- Describe the standard Medicare Part D benefit and who is likely
to enroll.
- Examine how individuals respond to drug benefit caps.
- Estimate the impact of drug co-payments on utilization, by therapeutic
class.
- Describe how co-payments affect compliance with statin therapy.
- Describe how we can strategically change co-pays in a budget-neutral
way to get better health outcomes.
Target
Audience
Pharmacists and Pharmacy Technicians
CE
Credit
A score of 70 percent is required to successfully complete
the CE quiz. You will have two opportunities to achieve a passing score.
The
Statement of Credit should be printed upon receipt; a duplicate copy
will be available in the participant's online transcript for further
viewing. Individuals must complete this program by October 17, 2008
to receive credit.
NCPA
is approved by the Accreditation Council for Pharmacy Education as a
provider of continuing pharmacy education. This program will provide
1.5 contact hour(s) (0.15 CEUs) of continuing pharmacy education credit
under the number 207-000-05-140-H04.
Faculty
Information
Geoffrey Joyce, Ph.D., Senior Economist,
RAND Corporation, Santa Monica, California; David McCaffrey,
Ph.D., Assistant Professor Social & Administrative Sciences,
University of Mississippi, School of Pharmacy, Oxford, Mississippi;
Ken Whittemore, R.Ph., MBA, Vice President Professional
and Regulatory Affairs, SureScripts, LLC, Alexandria, Virginia.
Faculty
Disclosure Statements
NCPA has a conflict of interest policy that requires course
faculty to disclose any real or apparent commercial financial affiliations
related to the content of their presentations/materials.
Commercial
Support Statement
This program is supported by an educational
grant from Pfizer Inc. |
 |
Software
Requirements
